Skip to main content
The Evidence Base has featured a ‘deep dive’ on the topic presented by Tijana Ignjatovic, Executive Director, and Kuldeep Singh, Executive Vice President, Genesis Research Group at ISPOR 2024: Understanding payer perceptions of health inequalities in health technology assessment and reimbursement decision-making.

Disparities in health outcomes and access to health care among different population groups are becoming increasingly important to be considered in health technology assessment (HTA) and reimbursement decision-making. To ensure that health inequalities are appropriately and systematically considered by all stakeholders, there is a need for a clear framework, better methods to measure inequality, and a shared understanding of how these factors should be considered alongside clinical outcomes.

In the ISPOR 2024 session titled, “Payer Perceptions of Health Inequalities in Reimbursement Decision Making: Implications for the Pharmaceutical Industry,” Kuldeep Singh and Tijana Ignjatovic of Genesis Research Group delved into this complex landscape. They shared results from a qualitative payer survey on perceptions of health equity and its role in decision-making, providing valuable insights into current stakeholder views on this critical issue.

Read more at The Evidence Base

The survey was carried out using our RPR stakeholder engagement solution. If you’d like to learn more about this, please get in touch via this form or email



111 River Street, Suite 1120
Hoboken, New Jersey 07030, US